Category Archives: Public Policy

Latest From Public Policy

Innovation Files: CSBI Tax Proposals Attempt to Bridge “Valley of Death”

CSBI-logo

Over at the Innovation Files, Joe Kennedy has posted an excellent summary of a set of tax reform proposals developed by the Coalition of Small Business Innovators (CSBI), of which BIO is a member. The proposals would increase investment and employment at small, research intensive companiesby allowing investors to take advantage of passive losses and research credits generated by the company. They would also allow companies to carry net operating losses forward to future years Read More >

Business and Investments, Public Policy  |  Leave a comment  |  Email This Post
Tags: , , ,

BIO Deputy General Counsel Testifies on Patent Reform

patent

On Wednesday, March 18, BIO’s Deputy Counsel for Intellectual Property, Hans Sauer, testified in front of the U.S. Senate Judiciary Committee regarding proposed reforms to the current U.S. patent system. The hearing was a chance for the Judiciary committee to listen to experts on what should be done to halt misuse of the patent system. In his remarks, Mr. Sauer noted that while BIO appreciates efforts by Congress to curb patent troll abuses, some of Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , , , , , , , , , ,

Blue Ribbon Study Panel Examines Surveillance and Detection Issues in Biodefense

Jim Greenwood

The Blue Ribbon Study Panel on Biodefense held the third of four meetings on Thursday, March 12, 2015. The goal of the Panel is to evaluate the United States’ level of preparedness for a natural or deliberate biological or chemical event and to develop actionable recommendations toward the aim of preparedness. The Blue Ribbon Study Panel on Biodefense will build off the work previously done by the 9/11 Commission and the Weapons of Mass Destruction Read More >

Health, Public Policy  |  Leave a comment  |  Email This Post
Tags: ,

BIO Chair Testifies Before Senate

BIO’s Chair and CEO of GlycoMimetics, Rachel King

BIO’s Chair and CEO of GlycoMimetics, Rachel King, testified before the Senate Committee on Small Business and Entrepreneurship today where she reinforced the need for patent protection incentives to encourage small business innovation. Ms. King also encouraged Congress to address weaknesses in the United States Patent and Trademark Office’s Inter Partes Review (IRP) system that allows abuses perpetrated against legitimate patent holders. Read her full testimony. You can read more about BIO’s position on patent Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , ,

BIO and University Organizations offer Support of STRONG Patents Act

shutterstock_26191726

On March 4, 2015, Senator Chris Coons (D-DE) introduced a new bill, The STRONG Patents Act of 2015. Sponsored alongside Sen. Richard Durbin (D-IL) and Sen. Mazie Hirono (D-HI), the bill is offered as a complement to House Judiciary Committee Chairman Goodlatte’s (R-VA) Innovation Act, which many in the biotech sector see as an imbalanced bill. The STRONG Patents Act of 2015 would target the abusive practices of patent trolls in a narrowly tailored setting, Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,